Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Immunohistochemistry (IHC)
1.2.4 In Situ Hybridization (ISH)
1.2.5 Next Generation Sequencing (NGS)
1.3 Market by Application
1.3.1 Global Companion Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Laboratories
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostics Market Perspective (2018-2033)
2.2 Companion Diagnostics Growth Trends by Region
2.2.1 Global Companion Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Companion Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Companion Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Companion Diagnostics Market Dynamics
2.3.1 Companion Diagnostics Industry Trends
2.3.2 Companion Diagnostics Market Drivers
2.3.3 Companion Diagnostics Market Challenges
2.3.4 Companion Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostics Players by Revenue
3.1.1 Global Top Companion Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Companion Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostics Revenue
3.4 Global Companion Diagnostics Market Concentration Ratio
3.4.1 Global Companion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostics Revenue in 2022
3.5 Companion Diagnostics Key Players Head office and Area Served
3.6 Key Players Companion Diagnostics Product Solution and Service
3.7 Date of Enter into Companion Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostics Breakdown Data by Type
4.1 Global Companion Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Companion Diagnostics Forecasted Market Size by Type (2024-2033)
5 Companion Diagnostics Breakdown Data by Application
5.1 Global Companion Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Companion Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Companion Diagnostics Market Size (2018-2033)
6.2 North America Companion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Companion Diagnostics Market Size by Country (2018-2023)
6.4 North America Companion Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Diagnostics Market Size (2018-2033)
7.2 Europe Companion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Companion Diagnostics Market Size by Country (2018-2023)
7.4 Europe Companion Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific Companion Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Companion Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Companion Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Diagnostics Market Size (2018-2033)
9.2 Latin America Companion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Companion Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Companion Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa Companion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Companion Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Companion Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Holdings
11.1.1 Roche Holdings Company Detail
11.1.2 Roche Holdings Business Overview
11.1.3 Roche Holdings Companion Diagnostics Introduction
11.1.4 Roche Holdings Revenue in Companion Diagnostics Business (2018-2023)
11.1.5 Roche Holdings Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Companion Diagnostics Introduction
11.2.4 Abbott Laboratories Revenue in Companion Diagnostics Business (2018-2023)
11.2.5 Abbott Laboratories Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Companion Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Companion Diagnostics Introduction
11.4.4 Agilent Technologies Revenue in Companion Diagnostics Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 Life Technologies
11.5.1 Life Technologies Company Detail
11.5.2 Life Technologies Business Overview
11.5.3 Life Technologies Companion Diagnostics Introduction
11.5.4 Life Technologies Revenue in Companion Diagnostics Business (2018-2023)
11.5.5 Life Technologies Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Companion Diagnostics Introduction
11.6.4 GE Healthcare Revenue in Companion Diagnostics Business (2018-2023)
11.6.5 GE Healthcare Recent Development
11.7 Agendia
11.7.1 Agendia Company Detail
11.7.2 Agendia Business Overview
11.7.3 Agendia Companion Diagnostics Introduction
11.7.4 Agendia Revenue in Companion Diagnostics Business (2018-2023)
11.7.5 Agendia Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Detail
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Companion Diagnostics Introduction
11.8.4 Qiagen Revenue in Companion Diagnostics Business (2018-2023)
11.8.5 Qiagen Recent Development
11.9 Genomic Health
11.9.1 Genomic Health Company Detail
11.9.2 Genomic Health Business Overview
11.9.3 Genomic Health Companion Diagnostics Introduction
11.9.4 Genomic Health Revenue in Companion Diagnostics Business (2018-2023)
11.9.5 Genomic Health Recent Development
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Detail
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Companion Diagnostics Introduction
11.10.4 Myriad Genetics Revenue in Companion Diagnostics Business (2018-2023)
11.10.5 Myriad Genetics Recent Development
11.11 Advanced Cell Diagnostics
11.11.1 Advanced Cell Diagnostics Company Detail
11.11.2 Advanced Cell Diagnostics Business Overview
11.11.3 Advanced Cell Diagnostics Companion Diagnostics Introduction
11.11.4 Advanced Cell Diagnostics Revenue in Companion Diagnostics Business (2018-2023)
11.11.5 Advanced Cell Diagnostics Recent Development
11.12 Danaher
11.12.1 Danaher Company Detail
11.12.2 Danaher Business Overview
11.12.3 Danaher Companion Diagnostics Introduction
11.12.4 Danaher Revenue in Companion Diagnostics Business (2018-2023)
11.12.5 Danaher Recent Development
11.13 Applied Proteomics
11.13.1 Applied Proteomics Company Detail
11.13.2 Applied Proteomics Business Overview
11.13.3 Applied Proteomics Companion Diagnostics Introduction
11.13.4 Applied Proteomics Revenue in Companion Diagnostics Business (2018-2023)
11.13.5 Applied Proteomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Companion Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Immunohistochemistry (IHC)
Table 4. Key Players of In Situ Hybridization (ISH)
Table 5. Key Players of Next Generation Sequencing (NGS)
Table 6. Global Companion Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Companion Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Companion Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Companion Diagnostics Market Share by Region (2018-2023)
Table 10. Global Companion Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Companion Diagnostics Market Share by Region (2024-2033)
Table 12. Companion Diagnostics Market Trends
Table 13. Companion Diagnostics Market Drivers
Table 14. Companion Diagnostics Market Challenges
Table 15. Companion Diagnostics Market Restraints
Table 16. Global Companion Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Companion Diagnostics Market Share by Players (2018-2023)
Table 18. Global Top Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2022)
Table 19. Ranking of Global Top Companion Diagnostics Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Companion Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Companion Diagnostics Product Solution and Service
Table 23. Date of Enter into Companion Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Companion Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Companion Diagnostics Revenue Market Share by Type (2018-2023)
Table 27. Global Companion Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Companion Diagnostics Revenue Market Share by Type (2024-2033)
Table 29. Global Companion Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Companion Diagnostics Revenue Market Share by Application (2018-2023)
Table 31. Global Companion Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Companion Diagnostics Revenue Market Share by Application (2024-2033)
Table 33. North America Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Companion Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Companion Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Companion Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Companion Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Companion Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Companion Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Companion Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 48. Roche Holdings Company Detail
Table 49. Roche Holdings Business Overview
Table 50. Roche Holdings Companion Diagnostics Product
Table 51. Roche Holdings Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 52. Roche Holdings Recent Development
Table 53. Abbott Laboratories Company Detail
Table 54. Abbott Laboratories Business Overview
Table 55. Abbott Laboratories Companion Diagnostics Product
Table 56. Abbott Laboratories Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 57. Abbott Laboratories Recent Development
Table 58. Thermo Fisher Scientific Company Detail
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Companion Diagnostics Product
Table 61. Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 62. Thermo Fisher Scientific Recent Development
Table 63. Agilent Technologies Company Detail
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies Companion Diagnostics Product
Table 66. Agilent Technologies Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 67. Agilent Technologies Recent Development
Table 68. Life Technologies Company Detail
Table 69. Life Technologies Business Overview
Table 70. Life Technologies Companion Diagnostics Product
Table 71. Life Technologies Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 72. Life Technologies Recent Development
Table 73. GE Healthcare Company Detail
Table 74. GE Healthcare Business Overview
Table 75. GE Healthcare Companion Diagnostics Product
Table 76. GE Healthcare Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 77. GE Healthcare Recent Development
Table 78. Agendia Company Detail
Table 79. Agendia Business Overview
Table 80. Agendia Companion Diagnostics Product
Table 81. Agendia Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 82. Agendia Recent Development
Table 83. Qiagen Company Detail
Table 84. Qiagen Business Overview
Table 85. Qiagen Companion Diagnostics Product
Table 86. Qiagen Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 87. Qiagen Recent Development
Table 88. Genomic Health Company Detail
Table 89. Genomic Health Business Overview
Table 90. Genomic Health Companion Diagnostics Product
Table 91. Genomic Health Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 92. Genomic Health Recent Development
Table 93. Myriad Genetics Company Detail
Table 94. Myriad Genetics Business Overview
Table 95. Myriad Genetics Companion Diagnostics Product
Table 96. Myriad Genetics Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 97. Myriad Genetics Recent Development
Table 98. Advanced Cell Diagnostics Company Detail
Table 99. Advanced Cell Diagnostics Business Overview
Table 100. Advanced Cell Diagnostics Companion Diagnostics Product
Table 101. Advanced Cell Diagnostics Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 102. Advanced Cell Diagnostics Recent Development
Table 103. Danaher Company Detail
Table 104. Danaher Business Overview
Table 105. Danaher Companion Diagnostics Product
Table 106. Danaher Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 107. Danaher Recent Development
Table 108. Applied Proteomics Company Detail
Table 109. Applied Proteomics Business Overview
Table 110. Applied Proteomics Companion Diagnostics Product
Table 111. Applied Proteomics Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)
Table 112. Applied Proteomics Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Companion Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Polymerase Chain Reaction (PCR) Features
Figure 4. Immunohistochemistry (IHC) Features
Figure 5. In Situ Hybridization (ISH) Features
Figure 6. Next Generation Sequencing (NGS) Features
Figure 7. Global Companion Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Companion Diagnostics Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Laboratories Case Studies
Figure 12. Other Case Studies
Figure 13. Companion Diagnostics Report Years Considered
Figure 14. Global Companion Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Companion Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Companion Diagnostics Market Share by Region: 2022 VS 2033
Figure 17. Global Companion Diagnostics Market Share by Players in 2022
Figure 18. Global Top Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Companion Diagnostics Revenue in 2022
Figure 20. North America Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Companion Diagnostics Market Share by Country (2018-2033)
Figure 22. United States Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Companion Diagnostics Market Share by Country (2018-2033)
Figure 26. Germany Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Companion Diagnostics Market Share by Region (2018-2033)
Figure 34. China Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Companion Diagnostics Market Share by Country (2018-2033)
Figure 42. Mexico Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Companion Diagnostics Market Share by Country (2018-2033)
Figure 46. Turkey Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Companion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Roche Holdings Revenue Growth Rate in Companion Diagnostics Business (2018-2023)
Figure 49. Abbott Laboratories Revenue Growth Rate in Companion Diagnostics Business (2018-2023)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostics Business (2018-2023)
Figure 51. Agilent Technologies Revenue Growth Rate in Companion Diagnostics Business (2018-2023)
Figure 52. Life Technologies Revenue Growth Rate in Companion Diagnostics Business (2018-2023)
Figure 53. GE Healthcare Revenue Growth Rate in Companion Diagnostics Business (2018-2023)
Figure 54. Agendia Revenue Growth Rate in Companion Diagnostics Business (2018-2023)
Figure 55. Qiagen Revenue Growth Rate in Companion Diagnostics Business (2018-2023)
Figure 56. Genomic Health Revenue Growth Rate in Companion Diagnostics Business (2018-2023)
Figure 57. Myriad Genetics Revenue Growth Rate in Companion Diagnostics Business (2018-2023)
Figure 58. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostics Business (2018-2023)
Figure 59. Danaher Revenue Growth Rate in Companion Diagnostics Business (2018-2023)
Figure 60. Applied Proteomics Revenue Growth Rate in Companion Diagnostics Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed